Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Triple Negative Breast Neoplasms × ganitumab × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Sarcoma 3 Sarcoma, Ewing 2 Ovarian Neoplasms 2 Insulin-Like Growth Factor I, Resistance To 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoid Tumor 2 Breast Neoplasms 2 Small Cell Lung Carcinoma 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdomyosarcoma 1 Recurrence 1 Rectal Neoplasms 1 Pleural Effusion, Malignant 1 Neuroendocrine Tumors 1 Neoplasms 1 Lymphoma 1 Lung Neoplasms 1 Jaundice 1 Gastrointestinal Neoplasms 1 Endocrine Gland Neoplasms 1 Colonic Neoplasms 1 Adenoma, Islet Cell 1 Adenocarcinoma 1

Interventions

Paclitaxel 33 pembrolizumab 30 Carboplatin 28 Cyclophosphamide 18 Albumin-Bound Paclitaxel 18 Taxes 15 130-nm albumin-bound paclitaxel 15 Doxorubicin 14 atezolizumab 13 Capecitabine 13 Cisplatin 11 Nivolumab 9 Docetaxel 8 olaparib 7 Gemcitabine 6 talazoparib 5 durvalumab 5 Everolimus 5 Biopsy 5 Bevacizumab 5 spartalizumab 4 pegfilgrastim 4 liposomal doxorubicin 4 eribulin 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 sacituzumab govitecan 3 entinostat 3 bintrafusp alfa protein, human 3 Trastuzumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡